| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002000195A3 Methods and compositions for treating pain of the mucous membrane |
| 08/15/2002 | US20020110577 Method and non-gelling composition for inhibiting post-surgical adhesions |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | CN1364170A Thiophene A2A receptor agaonists |
| 08/13/2002 | US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 08/13/2002 | US6432445 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP0831856B1 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/06/2002 | US6429217 Pharmacological drug combination in vagal-induced asystole |
| 08/06/2002 | US6428800 Mixture of bioactive glass and topical antibiotic |
| 08/01/2002 | WO2002058750A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 08/01/2002 | WO2002058749A2 Carrier with solid fibrinogen and solid thrombin |
| 08/01/2002 | WO2002058730A2 Compositions for treatment of ocular neovascularization |
| 08/01/2002 | WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | WO2002022166A3 Tweak receptor agonists as anti-angiogenic agents |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | US20020103257 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 08/01/2002 | CA2436139A1 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 07/31/2002 | EP1226830A2 Combination therapy involving a sodium-hydrogen exchanger type 1 or NHE-1 inhibitor for use in treatment of ischemia |
| 07/31/2002 | CN1361779A New compounds |
| 07/30/2002 | US6426071 Administering protein c |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002014320A3 Novel substituted diaryl azepine derivatives as integrin ligands |
| 07/25/2002 | WO2001068079A3 Viscoelastics for use in middle ear surgery |
| 07/25/2002 | CA2369212A1 Combination therapy |
| 07/24/2002 | EP1224179A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/24/2002 | EP1223986A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/23/2002 | US6423311 Mammals grafting cells with radiation |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002022776A3 Human coagulation factor vii variants |
| 07/18/2002 | US20020094998 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | CN1359294A Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel |
| 07/11/2002 | WO2002053525A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2000064911A9 Ligands for metabotropic glutamate receptors |
| 07/11/2002 | US20020091251 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 07/11/2002 | CA2433580A1 Tertiary perfluorocycloamines as a basis for gas transport emulsions and process for preparing thereof |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2002 | WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 07/03/2002 | EP1218026A2 Method to enhance healing of sternum after sternotomy |
| 07/03/2002 | CN1356902A IL-8 receptor antagonists |
| 07/02/2002 | US6414021 Vision defects |
| 06/27/2002 | WO2002050039A1 Urea and urethane derivatives as integrin inhibitors |
| 06/27/2002 | WO2002026935A3 TGF-β INHIBITORS AND METHODS |
| 06/27/2002 | WO2000056350A9 Methods of use of beta 1-integrin inhibitors |
| 06/26/2002 | EP0930878B1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002047728A2 Treatment of posterior capsule opacification |
| 06/20/2002 | WO2002047721A1 Silensed anti-cd28 antibodies and use thereof |
| 06/20/2002 | WO2001030328A3 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 06/20/2002 | WO2000067734A3 Use of phthalazine derivatives |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | CA2432736A1 Silenced anti-cd28 antibodies and use thereof |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1214408A1 Ribozymes used for restenosis prevention |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2001091775A3 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 06/13/2002 | US20020072540 For therapy, prophylaxis and diagnosis of respiratory distress syndrome or other pulmonary diseases that are associated with deficiency of lung surfactant |
| 06/13/2002 | US20020072499 Specifically an N-formyl-methionyl-leucyl ("f-Met-Leu") tri-or tetra-peptide; pathological fibrosis or those caused by trauma or surgery |
| 06/13/2002 | CA2436870A1 Substituted anthranilic acids |
| 06/12/2002 | EP1212616A2 Inhibitors of binding between proteins and macromolecular ligands |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1212000A1 Method of controlling body temperature while reducing shivering |
| 06/12/2002 | EP1005337A4 Pharmacologic drug combination in vagal-induced asystole |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353613A Pharmaceutical compositions |
| 06/06/2002 | WO2002043785A2 Intraocular implants for preventing transplant rejection in the eye |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | US20020068083 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210086A1 Promotion of wound healing |
| 06/05/2002 | EP1210046A1 Enhanced wound coverage to enhance wound healing |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002041827A2 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 05/30/2002 | CA2429817A1 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 05/29/2002 | EP1208855A1 Novel embolizing compositions |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208097A2 Substituted oxoazaheterocyclyl compounds |
| 05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/23/2002 | WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/22/2002 | EP1206275A2 Irrigation solution and method for inhibition of pain and inflammation |
| 05/16/2002 | WO2002003871A8 Use of a liquid medicament in surgical high pressure liquid jet devices |
| 05/16/2002 | WO2001089514A3 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent |